{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11975475", "DateCompleted": {"Year": "2002", "Month": "07", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "65", "Issue": "4", "PubDate": {"Year": "2002", "Month": "Apr"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolized cyclohexanedione moiety.", "Pagination": {"StartPage": "433", "EndPage": "438", "MedlinePgn": "433-8"}, "Abstract": {"AbstractText": ["Modification of the St. John's wort acylphloroglucinol constituent, hyperforin (1), by acylation, alkylation, and oxidation resulted in detrimental effects on the inhibition of the synaptosomal accumulation of serotonin, showing the existence of definite structure-activity relationships in this in vitro test system and highlighting the role of the enolized cyclohexanedione moiety for activity on neurotransmitter reuptake."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Chimica Organica e Industriale, Universit\u00e0 di Milano, Via Venezian 21, 20133 Milano, Italy. luisella.verotta@unimi.it"}], "Identifier": [], "LastName": "Verotta", "ForeName": "Luisella", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Appendino", "ForeName": "Giovanni", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Belloro", "ForeName": "Emanuela", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bianchi", "ForeName": "Federica", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sterner", "ForeName": "Olov", "Initials": "O"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lovati", "ForeName": "Marco", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bombardelli", "ForeName": "Ezio", "Initials": "E"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Bridged Bicyclo Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclohexanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Dopamine Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Neurotransmitter"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "hyperforin 3,5-dinitrobenzoate"}, {"RegistryNumber": "0", "NameOfSubstance": "hyperforin acetate"}, {"RegistryNumber": "0", "NameOfSubstance": "hyperforin trimethoxybenzoate"}, {"RegistryNumber": "DHD7FFG6YS", "NameOfSubstance": "Phloroglucinol"}, {"RegistryNumber": "RM741E34FP", "NameOfSubstance": "hyperforin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Bridged Bicyclo Compounds"}, {"QualifierName": [], "DescriptorName": "Chromatography, Thin Layer"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cyclohexanes"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Dopamine Antagonists"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Phloroglucinol"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Receptors, Neurotransmitter"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Infrared"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Terpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "4", "Day": "27", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "7", "Day": "3", "Hour": "10", "Minute": "1"}, {"Year": "2002", "Month": "4", "Day": "27", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11975475", "10.1021/np0105681", "np0105681"]}}], "PubmedBookArticle": []}